Jul 4, 2024, 03:22 | Blog

Updates from Upstate NY Cancer Symposium by Oncology Brothers

Oncology Brothers shared on X: "Updates from Upstate NY Cancer Symposium: India is now T20 Champions! Back…

Jul 2, 2024, 13:03 | Insight

Maciej M Mrugala: Updates in advanced urothelial carcinoma at the Mayo Clinic and University of Athens meeting

Petros Grivas shared a post by Maciej M Mrugala, Director-Neuro-Oncology Fellowship Program at Mayo Clinic on…

Jul 2, 2024, 11:31 | Blog

Challenges in non-muscle invasive bladder cancer by Ashish Kamat

Enrique Grande shared on X: . "Brilliant talk about challenges in…

Jul 2, 2024, 11:12 | Blog

Enrique Grande: Fabulous and inspiring view of the short term future of advanced bladder cancer

Enrique Grande shared a post on X: …

Jun 30, 2024, 16:16 | Blog

Gianluca Giannarini: Great joint ESUI - EAU Section Urological Imaging session

Gianluca Giannarini, Associate Editor of European Urology, Full Board Member of the EAU Guidelines Office, shared…

Jun 30, 2024, 14:19 | Insight

Reprogramming Tumor-Associated Macrophages with Glutamine Antagonist JHU083

Maria Babak shared a post by The Babak Lab on LinkedIn: "Absolutely thrilled to see…

Jun 30, 2024, 13:21 | Blog

Khurshid Guru’s book titled “A Patient’s Guide to Bladder Cancer”

Roswell Park Comprehensive Cancer Center shared a post on LinkedIn: “New Episode Alert! Dr. Khurshid…

Jun 28, 2024, 14:34 | Blog

María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial

María Natalia Gandur Quiroga shared on LinkedIn: . "Imfinzi Shows Significant Survival Benefits in NIAGARA…

Jun 26, 2024, 08:30 | Insight

IMFINZI (durvalumab) showed improved EFS and OS for MIBC in NIAGARA Phase III trial

First immunotherapy regimen before and after surgery to extend survival in bladder cancer Positive high-level results…

Jun 25, 2024, 03:54 | Insight

Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System

Maria Natalia Gandur Quiroga shared on LinkedIn: "Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring…

Jun 24, 2024, 02:32 | Insight

Laura Bukavina: Clear failure of clinical trials to represent the true population of Genitourinary cancer patients

Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X: …

Jun 23, 2024, 17:14 | Blog

Sarah Psutka: A masterclass across the spectrum of bladder cancer at UROonco24

Sarah Psutka, Urologic Oncologist, Associate Professor at University of Washington School of Medicine, shared on…

Jun 23, 2024, 04:34 | Insight

Ashish Kamat: IBCG scoring system and substratification model for IR NMIBC

Ashish Kamat, Endowed Professor of Urologic Oncology (Surgery) and Cancer Research at University of Texas MD…

Jun 22, 2024, 02:24 | Insight

Guru Sonpavde: ctDNA for Evaluating Minimal Residual Disease in Bladder Cancer

Guru Sonpavde, Phase I and GU Oncology Director at Advent Health Cancer Institute, posted on…

Jun 21, 2024, 05:08 | Insight

Enrique Grande: A Molecular-Directed Strategy with TP53 Mutation in small cell bladder cancer

Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post…

Jun 19, 2024, 07:50 | Blog

Roger Li: The final results of the CORE001 trial are out now in Nature Medicine

Patrick Hwu shared a post by Roger Li, Urologic oncologist at Moffitt Cancer Center, on…

Jun 18, 2024, 17:53 | Blog

Sabine D. Brookman-May: Older patients with NMIBC show more aggressive tumors

Sabine D. Brookman-May, Professor of Urology at Ludwig-Maximilians University, shared a post by Niyati Lobo, Consultant…

Jun 5, 2024, 12:44 | Blog

Tom Powles: Perhaps the most important long-term bladder cancer data at ASCO24

Tom Powles, Director of Barts Cancer Center, shared on X/Twitter: ''Perhaps the most important long-term…

Jun 4, 2024, 16:37 | Societies

Wafik S. El-Deiry: Great to run into my colleague David De Graff

Wafik S. El-Deiry, shared a post on X: “Great to run into my colleague, David De…

Jun 4, 2024, 10:19 | Insight

Earle Burgess: The big news in advanced urothelial (bladder) cancer at ASCO24 isn’t at ASCO24

Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared a post on LinkedIn: “The…

Jun 4, 2024, 09:39 | Societies

ASCO24 Day 4 Highlights by The Oncology Brothers

The Oncology Brothers shared on X: "ASCO24 Day 4 Highlights: 1. ICTAN: Adjuvant anti-EGFR duration…

Jun 1, 2024, 10:00 | Insight

Tom Powles: TROPICS-4 in heavily pretreated bladder cancer missed OS

Tom Powles, Director of Barts Cancer Center, shared on X: “TROPICS-4 (sacituzumab, govitecan versus chemo) in…

May 31, 2024, 11:54 | Blog

Tian Zhang: My top themes of ASCO24

Tian Zhang shared a post on X: "My top themes of ASCO24 for kidney cancer, prostate…

May 29, 2024, 09:04 | Societies

Shilpa Gupta: Glad to present our work on physician-reported 1L treatment patterns in 5 European countries

Enrique Grande, recently shared a post by Shilpa Gupta on X, adding: "We all always…

May 26, 2024, 11:35 | Insight

Bladder cancer highlights for ASCO24 by Tom Powles

Tom Powles, Director of Barts Cancer Center, shared on X/Twitter: "Bladder cancer highlights for ASCO24. Practice…

May 25, 2024, 15:15 | Blog

JJ Zhang: Bladder Cancer Advocacy Network's Seattle Walk to End Bladder Cancer was a huge success

Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of…

May 23, 2024, 11:34 | Blog

Petros Grivas: We became 1 family raising awareness for bladder cancer at Bladder Cancer Advocacy Network

Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of Washington…

May 22, 2024, 00:45 | Blog

Aliya Mahmood Khan: I'm thrilled to share that we will be presenting at the AACR Special Conference on Bladder Cancer

Aliya Mahmood Khan, Resident Physician in Broward Health, shared on X: "I'm thrilled to share…

May 21, 2024, 05:34 | Insight

Laura Bukavina: Gut microbiome may influence chemo response in bladder cancer patients

Nazli Dizman, A Hematology/Oncology Fellow at MD Anderson Cancer Center, shared a post by Laura…

May 20, 2024, 14:40 | Blog

Dimitra Bakaloudi: Great time at the bladder cancer walk in Seattle

Dimitra Bakaloudi, Postdoctoral GU Oncology Researcher at University of Washington, shared on X/Twitter: "We had a…

May 18, 2024, 10:52 | Insight

Laura Bukavina: Gut microbiome may influence chemo response in bladder cancer patients

Amanda Nizam, GU Medical Oncologist at Cleveland Clinic, shared a post by Laura Bukavina, Urologic…

May 16, 2024, 09:08 | Blog

Bogdana Schmidt: I am lucky to have an amazing team!

Bogdana Schmidt, urologic surgeon specializing in urologic oncology at the University of Utah, shared a post…

May 14, 2024, 09:21 | Drugs

Piotr Wysocki: Pembrolizumab prevents recurrence in BCG-resistant bladder cancer

Piotr Wysocki recently posted on LinkedIn: "Necchi A et al. published a phase II single-arm study…

May 13, 2024, 08:04 | Insight

Petros Grivas: We are getting ready for annual bladder cancer walk in Seattle Lake Sammamish

Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of Washington…

May 12, 2024, 07:49 | Blog

Dan Theodorescu: I’m thrilled to be a co-chair for the AACR Special Conference in Cancer Research

Dan Theodorescu, Director of Cedars-Sinai Cancer Center, made the following post on X: "I’m thrilled…

May 12, 2024, 01:23 | Societies

Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20

Cedars-Sinai Co-Chairs Special Conference in Cancer Research Covering Transformational Developments in Treatment In partnership with…

May 12, 2024, 00:24 | Insight

Karima Oualla: IBCG- AUA Bladder Cancer Forum

Karima Oualla, Professor of Medical Oncology at Hassan II University Hospital, shared a post on LinkedIn:…

May 11, 2024, 12:27 | Blog

Erman Akkus on GLP1 Agonists in T2DM and Risk of Urological Cancers

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “GLP1 Agonists in…

May 7, 2024, 10:25 | Career

Tom Powles has been named in TIME100 Health - Barts and The London School of Medicine and Dentistry

Toni Choueiri shared a post by Barts and The London School of Medicine and Dentistry…

May 6, 2024, 14:55 | Blog

Petros Grivas: Great chat on Bladder Cancer

Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of Washington…

May 3, 2024, 00:05 | Blog

Jeremy Teoh: ERBT could reduce the 1-year recurrence rate in NMIBC

Jeremy Teoh, Assistant Dean (External Affairs) & Associate Professor at CUHK Medicine, made the following…

May 1, 2024, 08:57 | Blog

Shilpa Gupta: Looking forward to debate session in bladder cancer

Shilpa Gupta, Director GU Oncology at Cleveland Clinic MD, shared a post by Ashish M.…

Apr 28, 2024, 12:18 | Blog

Laura Bukavina: Microbiome analysis of WGS of urine samples in bladder cancer is now interactive

Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared on X/Twitter:…

Apr 28, 2024, 10:46 | Insight

Sumanta Pal: Kicking off our Southern California Regional Collaborative journal club

Sumanta Pal, Head of the Kidney and Bladder Cancer Disease at City of Hope Medical…

Apr 26, 2024, 11:03 | Blog

Vivek Subbiah: FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer

Vivek Subbiah shared a post on X: "FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive…

Apr 24, 2024, 22:44 | Blog

Amol Akhade: Can u pronounce name of this latest approved drug by US FDA correctly?

Amol Akhade, Consultant medical oncologist at Suyog Cancer Clinics, shared a post on X: "Can u…

Apr 24, 2024, 09:13 | Drugs

FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer

FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…

Apr 14, 2024, 06:07 | Insight

Thomas Flaig: Honored to be able to speak at the annual NCCN meeting on the impact of recent research findings on the treatment of advanced bladder cancer

Thomas Flaig, Vice Chancellor for Research at University of Colorado Denver, shared on X/Twitter: "Honored…

Apr 1, 2024, 15:31 | Blog

Tom Powles: Easter paper of the month with Matt Galsky

Tom Powles, Director of Barts Cancer Center, shared a post on X: "Easter paper of…

Apr 1, 2024, 13:09 | Insight

Yüksel Ürün: This research suggests ctDNA could revolutionize pre-surgical decision-making and treatment strategies, ensuring more personalized care

Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter: "Circulating tumor DNA…

Mar 30, 2024, 09:30 | Blog

The updated Algorithm for Bladder Cancer - Oncology Brothers

Oncology Brothers shared on X/Twitter: "This is the updated Algorithm for Bladder Cancer. Nivo/Gem/Cis was not…

Mar 29, 2024, 19:30 | Insight

Maria Natalia Gandur Quiroga: New Insights on Bladder Cancer Invasion

Maria Natalia Gandur Quiroga shared on X/Twitter: "New Insights on Bladder Cancer Invasion. Unraveling a…

Mar 22, 2024, 06:20 | Societies

The 3rd World Bladder Cancer Patient Forum was a milestone event for our international community - World Bladder Cancer Patient Coalition

World Bladder Cancer Patient Coalition, posted on LinkedIn: "The 3rd World Bladder Cancer Patient Forum…

Mar 17, 2024, 19:51 | Insight

Tom Powles: New ESMO's guidlines for advanced bladder cancer Annals of Oncology - Enforumab Vedotin and pembrolizumab is the new standard of care

Tom Powles, Director of Barts Cancer Center, shared a post on X: "New ESMO's guidelines for…

Mar 15, 2024, 15:26 | Insight

Enfortumab+pembrolizumab combination as the 1st line treatment of choice for advanced urothelial cancer - summary by Piotr J. Wysocki

Piotr J. Wysocki, Professor of Medicine, Head of Department of Oncology at Jagiellonian University Hospital,…

Mar 9, 2024, 12:26 | Blog

Susanna F. Greer: Bladder cancer meets its match

Susanna F. Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the…

Feb 25, 2024, 16:11 | Insight

Aruni Ghose: Delighted to see our prospective blinded validation trial on the URO17 urinary bladder cancer biomarker published in BMC Urology by Springer Nature Group

Aruni Ghose, Focused Topic Network Member at European Cancer Organisation, shared a post on LinkedIn: ''Delighted…

Feb 23, 2024, 17:59 | Blog

Wafik El-Deiry: Rhode Island has one of the highest rates of bladder cancer in the US

Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…

Feb 21, 2024, 18:44 | Blog

Liang Cheng: NEWEST State-of-the Art -Review on Bladder Cancer Diagnosis and Treatment

Liang Cheng, Professor and Vice Chair for Translational Research at Warren Alpert Medical School of Brown…

Feb 21, 2024, 18:28 | Insight

Sabine Brookman-May: TAR-200 was safe and well tolerated, with encouraging preliminary efficacy in IR

Sabine Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, posted on X/Twitter: "Finally…

Feb 19, 2024, 17:05 | Drugs

Patrick Hwu: The FDA approved a groundbreaking treatment called TIL Therapy for advanced melanoma

Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on LinkedIn: "Today, the FDA…

Feb 1, 2024, 04:54 | Blog

Chris Boshoff: The European Medicines Agency (EMA) has accepted our application in collaboration with Astellas Pharma US and Merck for a combination therapy for advanced Urothelial Cancer

Jan 31, 2024, 17:49 | Insight

Earle Burgess: Initial results from a small pilot study in late mCRPC where there are limited to no effective treatment options available

Earle Burgess, Genitourinary Oncologist at Atrium Health Levine Cancer, shared on LinkedIn: "Enfortumab vedotin is…

Jan 30, 2024, 15:45 | Societies

Chiara Mercinelli: An honor to present Nure Combo trial at ASCO GU24

Chiara Mercinelli, Fellow Research Oncology Resident IRCCS San Raffaele, posted on X/Twitter: "It has been…

Jan 26, 2024, 17:52 | Blog

Chiara Mercinelli: Thrilled to present our recent work on muscle-invasive bladder cancer

Chiara Mercinelli, a Research Student on Genitourinary Oncology at Vita-Salute San Raffaele University, recently shared…

Jan 19, 2024, 08:43 | Drugs

María Natalia Gandur Quiroga: A significant advancement in bladder cancer treatment

María Natalia Gandur Quiroga shared on X/Twitter: "The article 'FGFR inhibition augments anti–PD-1 efficacy in…

Dec 19, 2023, 09:10 | Insight

Tom Powles: EV/pembro will transform the lives of many patients with this difficult disease

Tom Powles, Director of Barts Cancer Centre, shared a post on X/Twitter: "A big day…

Dec 8, 2023, 17:46 | Drugs

Earle Burgess: Interested in new treatments being developed for advanced (urothelial) bladder cancer?

Earle Burgess, Chief of the Genitourinary Oncology Section at Atrium Health, Levine Cancer Institute, shared…

Dec 5, 2023, 19:00 | Blog

Sumanta Pal: To all my friends in academia, industry, community practice and beyond

Sumanta Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared on…

Dec 4, 2023, 16:05 | Blog

Abhishek Shankar: My take away from Jammu CRABECON

Abhishek Shankar, Associate Professor in the Department of Radiation Oncology at All India Institute of…

Dec 4, 2023, 15:11 | Blog

Tom Powles: This is the next chapter IMO

Tom Powles, Director of Barts Cancer Centre, shared a post on X/Twitter: "Treatment for muscle…

Nov 23, 2023, 16:04 | Blog

Ashish M. Kamat: Our collaborative review on Lymph Node Dissection in GU cancers

Ashish M. Kamat, Professor of Urologic Oncology (Surgery) and Cancer Research at M.D. Anderson Cancer…

Nov 21, 2023, 13:57 | Blog

Vivek Subbiah: Honored to co-author with brilliant "Guru" of bladder cancer Guru Sonpavde.

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…

Nov 15, 2023, 17:32 | Insight

Omar Alhalabi: Have you treated bladder cancer with a component of "neuroendocrine" or "small cell" carcinoma?

Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, posted on Twitter. "Have you…

Nov 14, 2023, 03:56 | Insight

Guru P. Sonpavde: Honored to write this commentary...

Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X/Twitter: "Nivolumab…

Nov 7, 2023, 03:03 | Dialogues

5min OncoDaily Updates with Chandler Park: Vadim Koshkin discusses an innovative positive study of re-challenging patients with immunotherapy for metastatic bladder cancer patient

Oct 31, 2023, 04:25 | Dialogues

5min OncoDaily Updates with Chandler Park: Dr. Yüksel Urun on practice changing CheckMate 901 study for bladder cancer patients

[embed]https://www.youtube.com/watch?v=5qJ8T2SFHOA[/embed]

Oct 24, 2023, 19:58 | Blog

Elizabeth Plimack: Kudos to Amanda Nizam for winning Best ESMO2023 Poster in Urothelial

Elizabeth Plimack, Deputy Director Fox Chase Cancer Center, made the following post on Twitter: "Kudos…

Oct 23, 2023, 15:26 | Insight

Tom Powles: Enfortumab vedotin and Pembrolizumab improving PFS and OS by 55% and 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%)

Tom Powles, Director of Barts Cancer Centre, shared on Twitter: "Enfortumab vedotin and Pembrolizumab improving…

Oct 23, 2023, 15:24 | Insight

Why radiotherapy with concomitant chemotherapy is an excellent option for bladder preservation in bladder cancer patients

Pierre Blanchard, Full Professor of Radiation Oncology at Gustave Roussy Cancer Center, posted on his…

Oct 8, 2023, 17:16 | Blog

Sumanta K. Pal: I'm hugely indebted to Matt Galsky, not just for the chance to be a part of this Nature Medicine masterpiece he drove, but to see the joy of my pts doing well years out from chemo/IO without cystectomy.

Oct 2, 2023, 18:39 | Blog

Todd Waldman: We have a post-doctoral position available in my lab to study the function of the STAG2 tumor suppressor gene in the pathogenesis of human cancer.

Quoting Todd Waldman, Professor of Oncology, Molecular Biology, and Genetics and Director of the MD/PhD…

Aug 9, 2023, 06:42 | Blog

Great collaboration between Global Society of Rare GU tumors and International Bladder Cancer Group - Karima Oualla

Honored to be part of the fantastic Bladder Cancer Advocacy Network Think Tank, that took…

Jul 31, 2023, 15:46 | Blog

En bloc resection of bladder tumours has been proposed as an alternative technique - Edward Bruce-White

Standard bladder-cancer resection is conventionally performed by resecting the tumour piecemeal. En bloc resection of…

Jul 22, 2023, 19:34 | Blog

CRI congratulates SURGE Therapeutics on their completion of a $32 million Series B financing - Cancer Research Institute

CRI congratulates SURGE Therapeutics, led by former CRI CLIP Award Grantee Michael Goldberg, Ph.D, on their completion…

Jun 26, 2023, 19:13 | Blog

Patients with loss of Y chromosome (LOY) had poorer prognosis when their bladders were removed, but somewhat paradoxically, better overall survival rates when they received immune checkpoint inhibitors

Jun 7, 2023, 10:49 | Drugs

Ph3 data is eagerly anticipated - Omar Alhalabi

Beautiful balanced discussion of the buzzing field of Bladder Cancer by Bourlon Maite from INCMNSZMX.…

Jun 2, 2023, 06:05 | Insight

Promoting Bladder Cancer Awareness: Breakthrough Research from Penn State College of Medicine and Hershey Medical Center

Penn State College of Medicine, Penn State Cancer Institute, and Hershey Medical Center. "Did you…